ArticleJAMA otolaryngology-- head & neck surgery2022
Assessment of the Cost Burden of Episodic Recurrent Vestibular Vertigo in the US.
Article in JAMA otolaryngology-- head & neck surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.
- Investigation of Vestibular Dysfunction Requires Renewed Research Enthusiasm.Journal of the Association for Research in Otolaryngology : JARO · 2026Pooled it
- Comparative effectiveness and safety of preventive treatments for vestibular migraine: a systematic review and network meta-analysis.BMC neurology · 2025Pooled it
- Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo: A Nonrandomized Clinical Trial.JAMA network open · 2025Trial
- Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry.Annals of clinical and translational neurology · 2026Article
- Long-term economic and welfare consequences of Ménière's disease: a Danish nationwide matched cohort study, 2002-2016.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Brain computed tomography (CT) findings in patients with vertigo and without focal neurological abnormalities in the emergency department of a tertiary center in Saudi Arabia: a retrospective study.BMC emergency medicine · 2026Article
- Prevalence and direct costs of vestibular disease in France - matched case-control study results from the 2022 and 2023 french health data system.Cost effectiveness and resource allocation : C/E · 2026Article
- Optimizing Dizziness Management: Impact of Audiology Triage on Care Efficiency.The Laryngoscope · 2026Article
- Article
- Patient Perspectives on Episodic Dizziness and a Hypothetical At-Home Diagnostic Tool.Journal of patient experience · 2026Article
- Sex and age differences in the management of dizziness/vertigo in primary care: a retrospective population-based study.BMC primary care · 2025Article
- Comparison of gadolinium-enhanced MRI of the inner ear with definite Meniere's disease in the detection of endolymphatic hydrops between intratympanic and intravenous injection.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025Article
- Clinical characteristics and caloric testing in patients with light or heavy cupula of the horizontal semicircular canal.Frontiers in neurology · 2025Article
- Improving the Diagnostic Workup of Vertigo: A Multidisciplinary Review.Spartan medical research journal · 2025Review
- Labor market effects of rehabilitation for patients diagnosed with dizziness - a Danish nationwide register-based cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024Article
- Prevalence of vestibular disease in France: analysis of prescription data from a national health insurance database.Journal of neurology · 2024Article
- Healthcare Costs due to Dizziness/Vertigo in Korea: Analyses Using the Public Data of Health Insurance Review & Assessment Service.Journal of Korean medical science · 2024Article
- Episodic Vertigo: A Narrative Review Based on a Single-Center Clinical Experience.Audiology research · 2023Article
- Spinning Through History: Evolution of the Concept of Vestibular Migraine.Otology & neurotology open · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Understanding of the economic burden of recurrent vestibular causes of vertigo and areas contributing to the cost is needed. Objective: To analyze and identify the factors contributing to the direct medical costs associated with Ménière disease (MD), vestibular migraine (VM), and benign paroxysmal positional vertigo (BPPV). Design, Setting, and Participants: This economic evaluation used MarketScan Commercial Database claims data from 2018 to identify the non-Medicare patient population with the diagnoses of MD, VM, or BPPV. Data were analyzed January 1 to December 31, 2018. Main Outcomes and Measures: The total direct medical costs associated with MD, VM, and BPPV. Results: A total of 53 210 patients (mean [SD] age, 47.8 [11.8] years; 67.6% female) were included in this study, with 34 738 normal comparisons. There were 5783 (10.9%) patients with MD, 3526 (6.6%) patients with VM, and 43 901 (82.5%) patients with BPPV in the data set. Mean age and sex were different across the different vestibular disorders. Across the different groups, patients with no comorbidities or with a Charlson Comorbidity Index score of zero ranged from 98.4% to 98.8%. Around 5% of patients were hospitalized with inpatient stay lasting between 4.6 and 5.2 days. After adjusting for age, sex, and comorbidities, there were large differences in mean adjusted annual payments/direct costs across the different groups (MD, $9579; VM, $11 371; and BPPV, $8247). This equated to a total incremental estimated cost of $60 billion compared with the normal population. The number of outpatient brain magnetic resonance imaging or computed tomography scans per patient ranged anywhere from 1 to 20, while the number of inpatient brain magnetic resonance imaging or computed tomography scans per patient ranged anywhere from 1 to 6. A heat map of the total cost expenditure indicated that the costs were concentrated around the Midwest, Lake Michigan, and the East Coast. Conclusions and Relevance: In this economic evaluation, the 3 most common causes of recurrent vertigo-MD, VM, and BPPV-had considerable medical costs associated with them. Extraneous imaging orders and vestibular testing are factors to consider for cost reduction. However, further research and widespread education is needed to optimize the diagnosis, treatment, and care of patients presenting with vestibular disorders or dizziness.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.